POPLINE Database Topic: Injectable Contraceptives This feed contains the latest information on Injectable Contraceptives added to the POPLINE database. http://db.jhuccp.org/ics-wpd/popweb/graphics/infopoprss.gif POPLINE Database, The INFO Project en-us 8/27/2010 Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception. [Descriptive study on contraceptive requirements for clinical trials in Spain. Do we need a debate?] Contraceptive failure of Depo-Provera�: long-acting reversible contraceptive (LARC) methods do fail too. Contraception and gynaecological care. The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents. Fabrication, characterization and in vivo studies of biodegradable gamma sterilized injectable microparticles for contraception. Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use. Cost savings from the provision of specific methods of contraception in a publicly funded program. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women. Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis--a pilot study. How does gestational diabetes affect postpartum contraception in nondiabetic primiparous women? New technologies in contraception. Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate. Contraceptive failure with Depo-Provera� [letter] [Weight gain due to hormonal contraception: myth or truth?] Steroidal contraceptives: effect on bone fractures in women. Rates of follow-up and repeat pregnancy in the 12 months after first-trimester induced abortion. Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection. Progestogen-only contraceptives and the risk of stroke: a meta-analysis.